Literature DB >> 10443888

Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects.

P Parchi1, A Giese, S Capellari, P Brown, W Schulz-Schaeffer, O Windl, I Zerr, H Budka, N Kopp, P Piccardo, S Poser, A Rojiani, N Streichemberger, J Julien, C Vital, B Ghetti, P Gambetti, H Kretzschmar.   

Abstract

Phenotypic heterogeneity in sporadic Creutzfeldt-Jakob disease (sCJD) is well documented, but there is not yet a systematic classification of the disease variants. In a previous study, we showed that the polymorphic codon 129 of the prion protein gene (PRNP), and two types of protease-resistant prion protein (PrP(Sc)) with distinct physicochemical properties, are major determinants of these variants. To define the full spectrum of variants, we have examined a series of 300 sCJD patients. Clinical features, PRNP genotype, and PrP(Sc) properties were determined in all subjects. In 187, we also studied neuropathological features and immunohistochemical pattern of PrP(Sc) deposition. Seventy percent of subjects showed the classic CJD phenotype, PrP(Sc) type 1, and at least one methionine allele at codon 129; 25% of cases displayed the ataxic and kuru-plaque variants, associated to PrP(Sc) type 2, and valine homozygosity or heterozygosity at codon 129, respectively. Two additional variants, which included a thalamic form of CJD and a phenotype characterized by prominent dementia and cortical pathology, were linked to PrP(Sc) type 2 and methionine homozygosity. Finally, a rare phenotype characterized by progressive dementia was linked to PrP(Sc) type 1 and valine homozygosity. The present data demonstrate the existence of six phenotypic variants of sCJD. The physicochemical properties of PrP(Sc) in conjunction with the PRNP codon 129 genotype largely determine this phenotypic variability, and allow a molecular classification of the disease variants.

Entities:  

Mesh:

Year:  1999        PMID: 10443888

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  385 in total

1.  Mapping the parameters of prion-induced neuropathology.

Authors:  M P Stumpf; D C Krakauer
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-12       Impact factor: 11.205

Review 2.  Genetic PrP Prion Diseases.

Authors:  Mee-Ohk Kim; Leonel T Takada; Katherine Wong; Sven A Forner; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-05-01       Impact factor: 10.005

3.  Precipitous Deterioration of Motor Function, Cognition, and Behavior.

Authors:  Mireya Fernández-Fournier; David C Perry; Maria Carmela Tartaglia; Mary de May; Adam Boxer; Giovanni Coppola; Chadwick W Christine; Eric J Huang; William W Seeley; Bruce L Miller; Steven J DeArmond; Lea T Grinberg; Michael D Geschwind
Journal:  JAMA Neurol       Date:  2017-05-01       Impact factor: 18.302

4.  14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan.

Authors:  Katsuya Satoh; Susumu Shirabe; Hiroto Eguchi; Akira Tsujino; Katsumi Eguchi; Akira Satoh; Mitsuhiro Tsujihata; Masami Niwa; Shigeru Katamine; Saiko Kurihara; Hidenori Matsuo
Journal:  Cell Mol Neurobiol       Date:  2006-02       Impact factor: 5.046

5.  Primary white matter involvement in sporadic-type Creutzfeldt-Jakob disease? Which came first, the chicken or the egg?

Authors:  Walter Kucharczyk; Catherine Bergeron
Journal:  AJNR Am J Neuroradiol       Date:  2004 Jun-Jul       Impact factor: 3.825

6.  Agent strain variation in human prion disease: insights from a molecular and pathological review of the National Institutes of Health series of experimentally transmitted disease.

Authors:  Piero Parchi; Maura Cescatti; Silvio Notari; Walter J Schulz-Schaeffer; Sabina Capellari; Armin Giese; Wen-Quan Zou; Hans Kretzschmar; Bernardino Ghetti; Paul Brown
Journal:  Brain       Date:  2010-09-07       Impact factor: 13.501

7.  An atypical phenotype of CJD associated with the E200K mutation in the prion protein gene.

Authors:  Carlo Masullo; Alessandra Bizzarro; Valeria Guglielmi; Elisabetta Iannaccone; Giacomo Minicuci; Maria Gabriella Vita; Sabina Capellari; Piero Parchi; Serenella Servidei
Journal:  Neurol Sci       Date:  2010-08-21       Impact factor: 3.307

8.  Report of the Working Group 'Overall Blood Supply Strategy with Regard to Variant Creutzfeldt-Jakob Disease (vCJD)': Statement on the Development and Implementation of Test Systems Suitable for the Screening of Blood Donors for vCJD - Dated September 17, 2008.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

9.  The region approximately between amino acids 81 and 137 of proteinase K-resistant PrPSc is critical for the infectivity of the Chandler prion strain.

Authors:  Ryo Shindoh; Chan-Lan Kim; Chang-Hyun Song; Rie Hasebe; Motohiro Horiuchi
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

10.  Diagnosis of human prion disease.

Authors:  Jiri G Safar; Michael D Geschwind; Camille Deering; Svetlana Didorenko; Mamta Sattavat; Henry Sanchez; Ana Serban; Martin Vey; Henry Baron; Kurt Giles; Bruce L Miller; Stephen J Dearmond; Stanley B Prusiner
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.